Latest White Papers
- Random
Featured News
Latest News
- Title
- Most Views
- Recently Added
- Ordering
- Random
QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT ...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to ...
Cold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias Janowitz led a ...
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is ...
Latest Updates
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, announced the closing of a $40M Series ...
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, announced the closing of a $40M Series A financing round.
The round was led by Khosla Ventures and Ahren Innovation Capital, with ...
ImmunityBio, Inc.an immunotherapy company, announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin ...
ImmunityBio, Inc.an immunotherapy company, announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, unveiled Cell Q™, the first automated quality ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, unveiled Cell Q™, the first automated quality control (QC) workcell for cell therapy manufacturing. Cell Q™ addresses a critical challenge.
The ...
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the ...
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technology, which is the first in CSafe's CGT Cryo ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Desmopressin Acetate for Injection in the United States as a therapeutic ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Desmopressin Acetate for Injection in the United States as a therapeutic equivalent generic for DDAVP® for Injection (Desmopressin Acetate) approved by the U.S.
Food and ...
Fresenius, via its operating company Fresenius Kabi, announced the immediate U.S. availability of Tyenne® (tocilizumab-aazg), a biosimilar of Actemra® (tocilizumab). Tyenne®, for use in the treatment ...
Fresenius, via its operating company Fresenius Kabi, announced the immediate U.S. availability of Tyenne® (tocilizumab-aazg), a biosimilar of Actemra® (tocilizumab). Tyenne®, for use in the treatment of chronic autoimmune diseases, is available in an intravenous (IV) formulation.
Michael Sen, ...